Post‑transplant Herpesvirus‑8 DNA, Real‑Time PCR, Serum
Also known as: PTxplnt, Specialized, Human Herpes Virus, Txplnt, Services
Use
Human herpesvirus‑8 (HHV‑8) is associated with diseases such as Kaposi’s sarcoma and some lymphoproliferative disorders. Quantitative PCR can be useful for monitoring viremia in immunosuppressed post‑transplant patients, assisting in early detection of HHV‑8 reactivation or infection.
Special Instructions
Not provided.
Limitations
Performance characteristics of this lab‑developed test have been validated under CLIA standards but it has not been cleared or approved by the FDA.
Methodology
PCR-based (qPCR)
Biomarkers
HHV‑8
Microorganism
Result Turnaround Time
8-12 hours
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL preferred; 0.5 mL minimum
Minimum Volume
0.5 mL
Collection Instructions
Separate serum and send refrigerated; avoid sodium or lithium heparin tubes
Causes for Rejection
Samples collected in sodium or lithium heparin tubes are rejected
Other tests from different labs that may be relevant